NEXTCURE INC. - COMMO

NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML

15 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results

02 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

17 Oct 2023 08:05:00 By Nasdaq GlobeNewswire

NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease

26 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC

12 Sep 2023 08:05:00 By Nasdaq GlobeNewswire

NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

07 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease

05 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference

31 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results

03 Aug 2023 16:05:01 By Nasdaq GlobeNewswire

NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting

21 Jun 2023 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present at the JMP Securities Life Sciences Conference

09 May 2023 07:00:01 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2023 Financial Results

04 May 2023 16:05:02 By Nasdaq GlobeNewswire

NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference

11 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Full Year 2022 Financial Results

02 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

NextCure to Present at SVB Securities Global Biopharma Conference

07 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

NextCure to Present at Upcoming Investor Conferences

22 Nov 2022 08:00:02 By Nasdaq GlobeNewswire

NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates

15 Nov 2022 16:30:00 By Nasdaq GlobeNewswire

NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting

07 Nov 2022 08:05:00 By Nasdaq GlobeNewswire

NextCure Provides Update and Reports Third Quarter 2022 Financial Results

03 Nov 2022 16:15:00 By Nasdaq GlobeNewswire

NextCure to Present Trial in Progress Poster for NC525 at the 2022 American Society of Hematology (ASH) Annual Meeting

03 Nov 2022 09:15:00 By Nasdaq GlobeNewswire